Martin Auster, CHIEF FINANCIAL OFFICER at Ventyx Biosciences, Inc. (VTYX), sold 1,405 shares at $5.40 ($8K) on 2024-04-02, disclosed to the SEC on 2024-04-03.
Open-market sale of $8k VTYX by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VTYX | SELL | 2023-06-07 | $1.9M | — | Filing → |
| VTYX | SELL | 2023-04-27 | $2.1M | — | Filing → |
| VTYX | SELL | 2023-04-19 | $231K | — | Filing → |